Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Alendronate Reduces the Excretion of Risk Factors for Calcium Phosphate Stone Formation in Postmenopausal Women with Osteoporosis
Urologia Internationalis, 09/14/09
Yasui T et al. – The results suggested that ALN not only improves BMD and osteoporosis, but also reduces the risk of calcium phosphate stone formation in postmenopausal women.
Related Articles
A perspective on male osteoporosis
Best Practice & Research: Clinical Rheumatology, 12/03/09
Relevance Score: 90%
The association between osteoporosis and static balance in elderly women
Osteoporosis International, 11/30/09
Relevance Score: 89%
Urinary cadmium, osteopenia, and osteoporosis in the US population
Osteoporosis International, 11/30/09
Relevance Score: 89%
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Clinical Interventions in Aging, 11/12/09
Relevance Score: 89%
U.S. Hip Fracture Rate Could Drop 25 Percent With Aggressive Osteoporosis Prevention
ScienceDaily, 11/06/09
Relevance Score: 89%
Today in Stone Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of the Accordion stone-trapping device: in vitro results from an artificial ureterolithotripsy model
Urological Research - Urolithiasis, 12/04/09
Familiality of kidney stone disease in Iceland
Scandinavian Journal of Urology and Nephrology, 12/04/09
Recurrent Abdominal Pain in Childhood Urolithiasis
Pediatrics, 12/03/09
Article Search
Sponsor


See Latest Articles


